Core Laboratories (CLB) Revenue & Revenue Breakdown
Core Laboratories Revenue Highlights
Latest Revenue (Y)
$509.79M
Latest Revenue (Q)
$134.40M
Main Segment (Y)
Operating Segment Reservoir Description
Main Geography (Y)
Other Countries
Core Laboratories Revenue by Period
Core Laboratories Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $509.79M | 4.10% |
| 2022-12-31 | $489.74M | 4.14% |
| 2021-12-31 | $470.25M | -3.49% |
| 2020-12-31 | $487.27M | -27.08% |
| 2019-12-31 | $668.21M | -4.66% |
| 2018-12-31 | $700.85M | 6.22% |
| 2017-12-31 | $659.81M | 10.94% |
| 2016-12-31 | $594.74M | -25.43% |
| 2015-12-31 | $797.52M | -26.51% |
| 2014-12-31 | $1.09B | 1.09% |
| 2013-12-31 | $1.07B | 9.42% |
| 2012-12-31 | $981.08M | 8.09% |
| 2011-12-31 | $907.65M | 14.22% |
| 2010-12-31 | $794.65M | 14.25% |
| 2009-12-31 | $695.54M | -10.92% |
| 2008-12-31 | $780.84M | 16.45% |
| 2007-12-31 | $670.54M | 16.48% |
| 2006-12-31 | $575.69M | 19.08% |
| 2005-12-31 | $483.47M | 13.11% |
| 2004-12-31 | $427.43M | 5.37% |
| 2003-12-31 | $405.64M | 11.21% |
| 2002-12-31 | $364.75M | -3.14% |
| 2001-12-31 | $376.57M | 12.04% |
| 2000-12-31 | $336.10M | 10.67% |
| 1999-12-31 | $303.70M | 6.11% |
| 1998-12-31 | $286.20M | 33.18% |
| 1997-12-31 | $214.90M | 103.89% |
| 1996-12-31 | $105.40M | 31.59% |
| 1995-12-31 | $80.10M | - |
Core Laboratories generated $509.79M in revenue during NA 2023, up 4.10% compared to the previous quarter, and up 72.74% compared to the same period a year ago.
Core Laboratories Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $134.40M | 2.93% |
| 2024-06-30 | $130.58M | 0.73% |
| 2024-03-31 | $129.64M | 1.11% |
| 2023-12-31 | $128.21M | 2.29% |
| 2023-09-30 | $125.34M | -1.98% |
| 2023-06-30 | $127.88M | -0.37% |
| 2023-03-31 | $128.36M | 0.62% |
| 2022-12-31 | $127.57M | 1.27% |
| 2022-09-30 | $125.97M | 4.19% |
| 2022-06-30 | $120.90M | 4.86% |
| 2022-03-31 | $115.30M | -7.86% |
| 2021-12-31 | $125.14M | 6.06% |
| 2021-09-30 | $117.98M | -0.64% |
| 2021-06-30 | $118.75M | 9.56% |
| 2021-03-31 | $108.38M | -4.72% |
| 2020-12-31 | $113.75M | 7.94% |
| 2020-09-30 | $105.38M | -8.95% |
| 2020-06-30 | $115.74M | -24.06% |
| 2020-03-31 | $152.40M | -2.79% |
| 2019-12-31 | $156.78M | -9.48% |
| 2019-09-30 | $173.20M | 2.46% |
| 2019-06-30 | $169.04M | -0.09% |
| 2019-03-31 | $169.19M | -2.32% |
| 2018-12-31 | $173.21M | -4.91% |
| 2018-09-30 | $182.15M | 3.80% |
| 2018-06-30 | $175.47M | 3.21% |
| 2018-03-31 | $170.02M | -1.07% |
| 2017-12-31 | $171.85M | 3.37% |
| 2017-09-30 | $166.25M | 1.43% |
| 2017-06-30 | $163.90M | 3.86% |
| 2017-03-31 | $157.81M | 5.53% |
| 2016-12-31 | $149.54M | 4.22% |
| 2016-09-30 | $143.48M | -3.10% |
| 2016-06-30 | $148.07M | -3.63% |
| 2016-03-31 | $153.65M | -15.91% |
| 2015-12-31 | $182.72M | -7.37% |
| 2015-09-30 | $197.26M | -3.25% |
| 2015-06-30 | $203.89M | -4.57% |
| 2015-03-31 | $213.64M | -23.32% |
| 2014-12-31 | $278.62M | 0.90% |
| 2014-09-30 | $276.13M | 3.20% |
| 2014-06-30 | $267.56M | 1.77% |
| 2014-03-31 | $262.90M | -4.84% |
| 2013-12-31 | $276.28M | 1.14% |
| 2013-09-30 | $273.16M | 3.81% |
| 2013-06-30 | $263.14M | 0.85% |
| 2013-03-31 | $260.93M | 2.54% |
| 2012-12-31 | $254.46M | 3.68% |
| 2012-09-30 | $245.43M | -0.64% |
| 2012-06-30 | $247.01M | 5.47% |
| 2012-03-31 | $234.19M | -3.94% |
| 2011-12-31 | $243.79M | 5.38% |
| 2011-09-30 | $231.34M | 2.46% |
| 2011-06-30 | $225.78M | 9.22% |
| 2011-03-31 | $206.73M | -0.70% |
| 2010-12-31 | $208.19M | 4.50% |
| 2010-09-30 | $199.22M | 0.16% |
| 2010-06-30 | $198.90M | 5.61% |
| 2010-03-31 | $188.34M | 3.71% |
| 2009-12-31 | $181.60M | 8.22% |
| 2009-09-30 | $167.80M | 0.32% |
| 2009-06-30 | $167.26M | -6.49% |
| 2009-03-31 | $178.88M | -11.09% |
| 2008-12-31 | $201.19M | -0.66% |
| 2008-09-30 | $202.52M | 2.45% |
| 2008-06-30 | $197.69M | 10.17% |
| 2008-03-31 | $179.44M | - |
Core Laboratories generated $134.40M in revenue during Q3 2024, up 2.93% compared to the previous quarter, and up 105.10% compared to the same period a year ago.
Core Laboratories Revenue Breakdown
Core Laboratories Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Operating Segment Production Enhancement | $50.77M | $47.77M | $44.34M | $84.39M | $99.72M |
| Operating Segment Reservoir Description | $296.20M | $296.58M | $332.08M | $389.80M | $387.10M |
Core Laboratories's latest annual revenue breakdown by segment (product or service), as of Dec 22: Operating Segment Reservoir Description (85.37%), and Operating Segment Production Enhancement (14.63%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $35.55M | $34.24M | $34.62M | $37.28M | $38.63M | $38.08M | $35.48M | $30.58M | $35.86M | $33.16M | $32.48M | $24.40M | $24.55M | $19.13M | $24.73M | $42.43M | $41.61M | $52.38M | $51.16M | $48.86M |
| Service | $98.84M | $96.34M | $93.27M | $91.08M | $88.94M | $87.89M | $85.42M | $84.72M | $89.28M | $84.82M | $86.26M | $83.98M | $89.19M | $86.25M | $91.01M | $109.97M | $115.16M | $120.82M | $117.87M | $120.34M |
Core Laboratories's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Service (73.54%), and Product (26.46%).
Core Laboratories Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| UNITED STATES | $166.70M | $148.18M | $158.94M | $289.17M | $324.07M |
| Other Countries | $323.03M | $322.07M | $328.33M | $353.80M | $342.14M |
| CANADA | - | - | - | $25.24M | $34.63M |
Core Laboratories's latest annual revenue breakdown by geography, as of Dec 22: Other Countries (65.96%), and UNITED STATES (34.04%).
Core Laboratories Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| NOV | NOV | $8.58B | $2.19B |
| CHX | ChampionX | $3.76B | $906.53M |
| MRC | MRC Global | $3.41B | $806.00M |
| NEX | NexTier Oilfield Solutions | $3.24B | $945.09M |
| EFXT | Enerflex | $3.16B | $860.40M |
| OII | Oceaneering | $2.42B | $679.81M |
| DNOW | NOW | $2.32B | $563.00M |
| RES | RPC | $1.62B | $337.65M |
| VTOL | Bristow Group | $1.23B | $338.09M |
| WHD | Cactus | $1.10B | $293.18M |
| NOA | North American Construction Group | $957.22M | $297.03M |
| OIS | Oil States | $782.28M | - |
| NR | Newpark Resources | $749.60M | $179.01M |
| CLB | Core Laboratories | $509.79M | $134.40M |
| CCLP | CSI Compressco LP | $386.13M | $98.27M |
| SOI | Solaris Oilfield Infrastructure | $292.95M | $73.89M |
| GEOS | Geospace | $124.51M | $25.86M |
| NGS | Natural Gas Services Group | $121.17M | $38.49M |
| DRQ | Dril-Quip | $2.56M | $110.30M |
CLB Revenue FAQ
What is Core Laboratories’s yearly revenue?
Core Laboratories's yearly revenue for 2023 was $509.79M, representing an increase of 4.10% compared to 2022. The company's yearly revenue for 2022 was $489.74M, representing an increase of 4.14% compared to 2021. CLB's yearly revenue for 2021 was $470.25M, representing a decrease of -3.49% compared to 2020.
What is Core Laboratories’s quarterly revenue?
Core Laboratories's quarterly revenue for Q3 2024 was $134.4M, a 2.93% increase from the previous quarter (Q2 2024), and a 7.22% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $130.58M, a 0.73% increase from the previous quarter (Q1 2024), and a 2.11% increase year-over-year (Q2 2023). CLB's quarterly revenue for Q1 2024 was $129.64M, a 1.11% increase from the previous quarter (Q4 2023), and a 1.00% increase year-over-year (Q1 2023).
What is Core Laboratories’s revenue growth rate?
Core Laboratories's revenue growth rate for the last 3 years (2021-2023) was 8.41%, and for the last 5 years (2019-2023) was -23.71%.
What are Core Laboratories’s revenue streams?
Core Laboratories's revenue streams in c 22 are Operating Segment Production Enhancement, and Operating Segment Reservoir Description. Operating Segment Production Enhancement generated $50.77M in revenue, accounting 14.63% of the company's total revenue, up 6.30% year-over-year. Operating Segment Reservoir Description generated $296.2M in revenue, accounting 85.37% of the company's total revenue, down -0.13% year-over-year.
What is Core Laboratories’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of Core Laboratories was Operating Segment Reservoir Description. This segment made a revenue of $296.2M, representing 85.37% of the company's total revenue.